Similarly, in glioblastoma, GANT61 significantly reduced the cell viability, proliferation, and migration of tumour spheroids when paired with conditioned media from reactive astrocytes, indicating the drug’s potential for tackling aggressive tumours with high GLI1 expression [23]. Here, GLI1 is linked to neoplasm.